Stephen Liu

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Stephen Liu
May 29, 2025, 17:58 | Positive
Stephen Liu: Congratulations to the Newly Elected IASLC Board Members
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics, and Associate Professor at the…
May 24, 2025, 16:24 | Blog
Millie Das Will Participate in Oncology Forum 2025 at ASCO
Millie Das, Chief, Oncology Section at VA Palo Alto Health Care System, shared a post…
May 19, 2025, 12:48 | Blog
Narjust Florez: Adventures with Stephen Liu in Mexico City
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…
May 15, 2025, 16:30 | Blog
Stephen Liu: Proud of the Texas Lung Cancer Team for Winning a Bronze Medal at the 2025 Eventex Awards
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
May 11, 2025, 15:36 | Blog
Stephen Liu: Noemi Reguart Discusses PD1/VEGF Bispecifics in NSCLC at Rome Lung 2025
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
May 7, 2025, 09:48 | Blog
Stephen Liu: IASLC Podcast Spotlight - Dr. Bryant Lin’s Personal and Professional Journey with Lung Cancer
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
May 7, 2025, 09:31 | Blog
What Happens When a Lung Cancer Awareness Advocate Becomes a Patient? - IASLC 
IASLC shared a post on X: "What happens when a lung cancer awareness advocate becomes a…
May 5, 2025, 13:33 | Blog
Stephen Liu and Christine Lovly Highlight AACR25 Lung Cancer Updates on IASLC Podcast
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 28, 2025, 15:44 | Blog
Stephen Liu: Encouraging consideration of Tina Cascone for the 2025 SITC election
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 26, 2025, 13:18 | Blog
Stephen Liu: Great discussions on antibody drug conjugates - including the future of ADCs in NSCLC
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 25, 2025, 07:41 | Blog
Narjust Florez Reflects on Expanding the IASLC Podcast’s Global Reach and Impact
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…
Apr 24, 2025, 14:03 | Blog
Looking forward to discussing ADCs in solid tumors at AACR25 - Stephen Liu
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 24, 2025, 08:57 | Science
Daniel Sumarriva: Prevalence and molecular correlates of acquired EGFR resistance mutations in NSCLC
Daniel Sumarriva, Senior Director of Molecular Science Liaisons at Caris Life Sciences, shared a post…
Apr 21, 2025, 17:35 | Blog
Stephen Liu: Georgetown Cancer Institute is looking for a sarcoma specialist
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 21, 2025, 10:17 | Blog
Stephen Liu: PET surveillance in NSCLC after definitive therapy
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 21, 2025, 08:34 | Blog
Stephen Liu: Engaging Discussion on TROP2 ADCs in NSCLC
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 19, 2025, 19:01 | Science
Stephen Liu: Perspective on unintended consequences of patient portal access
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown…
Apr 13, 2025, 15:08 | Blog
10 Posts not to miss from the 2025 Texas Lung Cancer Conference – by Dr. Stephen Liu
​The 2025 Texas Lung Cancer Conference (#TexasLung25) took place from April 10–12 at the iconic…
Apr 13, 2025, 04:21 | Insight
10 Posts not to miss from the 2025 Texas Lung Cancer Conference – Dr. Estela Rodriguez
The 2025 Texas Lung Cancer Conference (#TexasLung25) took place from April 10–12 at the iconic…
Apr 7, 2025, 11:49 | Blog
Stephen Liu: Had a great time with Susie Scott discussing HER2 and lung cancer with PeerDirect
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on LinkedIn: "Had…
Mar 6, 2025, 13:51 | Societies
15 Posts Not To Miss From BTOG 2025
The 23rd Annual British Thoracic Oncology Group (BTOG) Conference took place from March 3-5 in…
Mar 3, 2025, 12:52 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Mar 3, 2025, 10:44 | Science
Joshua Reuss: Discordant IO response in biphasic diffuse pleural mesothelioma
Joshua Reuss, Thoracic Medical Oncologist at Georgetown Lombardi Comprehensive Cancer Center, shared a post on…
Mar 2, 2025, 06:55 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 26, 2025, 01:39 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 24, 2025, 12:46 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 23, 2025, 18:32 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 23, 2025, 01:42 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 9, 2025, 18:21 | Blog
The recent progress in treating small cell lung cancer
LUNGevity Foundation posted on LinkedIn: "Our latest blog highlights the recent progress in treating small…
Feb 4, 2025, 16:59 | Blog
Luis E Raez: Celebrating the III International thoracic Cancer Debates
Luis E Raez, Medical Director Memorial Cancer Institute & Co-Director MCI/FAU Florida Cancer Center of…
Feb 3, 2025, 16:55 | Blog
Stephen Liu: The KRAS G12C space in NSCLC at ITCD2025
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 3, 2025, 10:41 | Blog
Stephen Liu: A masterful talk on the next generation of checkpoint inhibitors
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Feb 3, 2025, 09:09 | Blog
Stephen Liu: Brilliant and passionate talk about AI and lung cancer at ITCD2025
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Jan 26, 2025, 14:09 | Blog
Stephen Liu: The 2025 DC Lung Cancer Conference
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on LinkedIn:…
Jan 20, 2025, 16:03 | Science
Amy Moore: Biomarker testing can help identify actionable mutations in patients with squamous NSCLC
Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a…
Jan 19, 2025, 22:23 | Blog
Stephen Liu: Explore the latest in lung cancer care at 2025 Texas Lung Cancer Conference
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post by IDEOlogy Health,…
Jan 18, 2025, 03:48 | Blog
Stephen Liu and Tina Cascone return as co-chairs for Texas Lung Cancer Conference 2025
TLC Conference shared a post on X: "It’s official: Drs. Stephen Liu and Tina Cascone are…
Jan 17, 2025, 21:20 | Blog
Stephen Liu: IASLC Reviewer Workshop applications open on January 24
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Jan 16, 2025, 12:46 | Blog
Explore the latest in lung cancer care at TexasLung25 - IDEOlogy Health
IDEOlogy Health shared a post on LinkedIn: "We’re excited to announce the 80+ faculty presenting…
Jan 14, 2025, 12:19 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Jan 7, 2025, 18:04 | Insight
Stephen Liu: What is the best way to assess response of brain metastases to systemic treatment?
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:…
Jan 7, 2025, 13:33 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Jan 3, 2025, 21:19 | Science
Luis Raez: We have a lot of survivors on osimertinib alone that will need second-line therapy in the future
Luis Raez, Medical Director and Chief Scientific Officer at Memorial Cancer Institute, shared a post…
Dec 25, 2024, 22:32 | Insight
Stephen Liu: Perioperative osimertinib for resectable EGFR NSCLC
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: “Perioperative…
Dec 22, 2024, 17:54 | Insight
Stephen Liu: The seminal IPASS trial in EGFR NSCLC
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: “In…
Dec 22, 2024, 10:44 | Science
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Dec 15, 2024, 12:48 | Blog
Stephen Liu: Amazing group of trainees and junior faculty at the 2024 EGFR Resisters Research Summit
Stephen Liu shared on LinkedIn: "Such an amazing group of trainees and junior faculty at the…
Dec 12, 2024, 13:36 | Blog
Stephen Liu: Join the IASLC Immunotherapy for Lung Cancer Regional Series
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on LinkedIn: "Join…
Nov 27, 2024, 19:58 | Insight
Stephen Liu: Phase III SKYSCRAPER-01 study is negative for OS at final analysis
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: "Press…
Nov 20, 2024, 19:12 | Blog
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC
IASLC (The International Association for the Study of Lung Cancer) shared a post on X:…
Nov 20, 2024, 13:28 | Blog
Stephen Liu: Discussing first-line therapy for EGFR NSCLC at the MaTOS meeting
Stephen Liu, Associate Professor of Medicine at Georgetown University, posted on LinkedIn: "Join us this…
Nov 18, 2024, 17:34 | Blog
NY Lung 24 Highlights by Isabel Preeshagul
The NY Lung 24 (19th Annual New York Lung Cancers Symposium) took place on November…
Nov 18, 2024, 16:59 | Blog
Refining the First Strike Against EGFR-Mutated Advanced NSCLC - PeerView Institute for Medical Education
PVI (PeerView Institute for Medical Education) shared a post on LinkedIn: "Join the lung cancer…
Nov 14, 2024, 15:49 | Blog
Stephen Liu: Proud to co-host the official IASLC podcast with Narjust Florez
Stephen Liu, Associate Professor of Medicine at Georgetown University, posted on LinkedIn: "Proud to co-host…
Nov 11, 2024, 17:12 | Blog
Stephen Liu: The Importance of Waiting for Biomarker Results in NSCLC
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: "It…
Nov 3, 2024, 13:55 | Insight
Highlights from JLCS24 by Stephen Liu
The 65th Annual Meeting of the Japanese Lung Cancer Society was held at PACIFICO Yokohama…
Nov 2, 2024, 03:06 | Blog
In the new episode of Lung Cancer Considered, host Stephen Liu previews the upcoming HTTR24 - IASLC
IASLC shared the following on X: “In this episode of Lung Cancer Considered, host Stephen…
Nov 1, 2024, 08:03 | Blog
Stephen Liu: Discussion on first-line management of EGFR NSCLC with Zosia Piotrowska
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Oct 23, 2024, 18:22 | Insight
Stephen Liu: What role does surgery play for patients with stage IV NSCLC?
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a post…
Oct 13, 2024, 22:27 | Insight
Stephen Liu: Analysis of locoregional relapse after segmentectomy in JCOG0802
Stephen Liu shared a post on X: “Analysis of locoregional relapse after segmentectomy in JCOG0802.…
Oct 9, 2024, 16:03 | OncoDaily Pulse
Inside OncoDaily Party Barcelona
On September 13, 2024, OncoDaily Party took place at the Chiringuito Mokai Beach Bar in Barcelona, Spain.…
Oct 5, 2024, 16:04 | Societies
Highlights From ILCS24
The 6th International Lung Cancer Summit was held in Lausanne, Switzerland on October 4, 2024,…
Oct 5, 2024, 12:11 | Blog
Biagio Ricciuti: Stephen Liu on the evolving treatment landscape for SCLC
Biagio Ricciuti shared a post on X: "Comprehensive overview of the evolving treatment landscape for…
Oct 2, 2024, 14:41 | Insight
Stephen Liu: Phase Ib study of naporafenib with rineterkib or trametinib in NSCLC
Stephen Liu shared a post on X about a recent paper by David Planchard et…
Oct 1, 2024, 15:46 | Blog
Stephen Liu: It’s my first ASTRO
Stephen Liu shared a post on X: "It’s my first ASTRO! Hopefully not my last!"…
Oct 1, 2024, 10:23 | Blog
Stephen Liu: The optimal duration of immunotherapy for NSCLC at DCLung24
Stephen Liu shared a post on X: "Dr. Matthew Lee from Montefiore, ME Cancer Center,…
Sep 26, 2024, 16:11 | Blog
Chandler Park: Learning the latest cutting edge data to help our cancer patients at ESMO 24
Chandler Park shared a post on Linkedin: ''ESMO was FUN! Loved learning the latest cutting…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 18, 2024, 23:22 | Insight
Stephen Liu: Update from TROPION-Lung01
Stephen Liu shared a post on X: “Update from TROPION-Lung01 presented at WCLC24 and now Journal…
Sep 18, 2024, 06:12 | Blog
Stephen Liu: Great scientific discussions at ESMO24
Stephen Liu shared a post on X: "In Barcelona for ESMO24 for just a few…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 11, 2024, 06:39 | Blog
Stephen Liu: Looking forward to discussing updates in ADCs for lung cancer at WCLC24
Stephen Liu shared a post on X: “Looking forward to WCLC24 - join us for lunch…
Sep 11, 2024, 04:28 | Societies
Dr. Coral Olazagasti's highlights from WCLC24 - Part 2
WCLC is a major international event focused on the latest advancements in lung cancer research, treatment,…
Sep 10, 2024, 14:47 | Blog
Stephen Liu: Congratulations to Dr. Julie Brahmer - this year’s Paul A. Bunn Jr. Scientific Award
Stephen Liu shared a post on X: "Congratulations to Dr. Julie Brahmer - this year’s Paul…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 7, 2024, 07:32 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Sep 6, 2024, 15:09 | Blog
Stephen Liu: "Do You Know Your Targets" Quiz show with Natasha Leighl and Ben Solomon
Stephen Liu shared a post on LinkedIn: "Going to WCLC24? Join the Meet the Expert session…
Aug 31, 2024, 20:07 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 30, 2024, 08:28 | Blog
The 50th anniversary of the IASLC on Lung Cancer Considered
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn: "This…
Aug 29, 2024, 16:56 | Insight
Stephen Liu: Overview of outcomes with 1L osimertinib
Stephen Liu shared a post on X about a recent paper by Kageaki Watanabe et…
Aug 27, 2024, 22:13 | Insight
Stephen Liu: Final anaysis of WJOG9717L
Stephen Liu shared a post on X: “Final anaysis of WJOG9717L (phase II osimertinib +/-…
Aug 20, 2024, 13:48 | Insight
Stephen Liu: So many great WCLC24 sessions to choose from
Stephen Liu shared a post on X: “So many great WCLC24 sessions to choose from.…
Aug 19, 2024, 08:17 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 14, 2024, 01:53 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 12, 2024, 14:02 | Blog
Stephen Liu: WCLC24 abstract titles released
Stephen Liu shared a post on X: "WCLC24 abstract titles released! Don't miss the plenary…
Aug 10, 2024, 17:53 | Insight
Stephen Liu: Biomarker results and the timing for lung cancer treatment
Stephen Liu shared on X: "It's critical to wait for biomarker results before starting treatment for…
Aug 9, 2024, 12:23 | Blog
The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at…
Aug 9, 2024, 01:47 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 6, 2024, 14:55 | Blog
Stephen Liu: Discussion on the emergence of immunotherapy in lung cancer
Stephen Liu shared on X: "Highlighting one of my favorite episodes of the IASLC podcast,…
Aug 4, 2024, 23:39 | Insight
HERALD EPOC1806 study explores trastuzumab deruxtecan in solid tumors with HER2 amplification by ctDNA
Stephen Liu shared a post on X: "HERALD EPOC1806 study published in JCO explored trastuzumab…
Aug 1, 2024, 06:47 | Blog
Stephen Liu: Best Practices for ALK-Positive NSCLC by Jessica Lin at DC Lung24
Stephen Liu shared a post on X: ''Jessica Lin from MGH Thoracic Oncology will discuss…
Jul 29, 2024, 21:28 | Insight
RWO with chemotherapy for patients who progress after PACIFIC regimen
Stephen Liu shared a post on X about a recent paper by Hayato Kawachi et al.…
Jul 29, 2024, 09:20 | Insight
PD-L1 and durvalumab after chemoradiation for stage III NSCLC in Netherlands Cancer Registry
Stephen Liu shared on X about a recent paper by Damhuis Ram et al. titled…
Jul 28, 2024, 10:33 | Blog
Stephen Liu: Dr. Christine Lovly about biomarker testing in lung cancer at DC Lung 24
Stephen Liu shared on X: "Dr. Christine Lovly will help us better understand biomarker testing…
Jul 26, 2024, 00:16 | Insight
Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy
Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…
Jul 25, 2024, 06:32 | Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 21, 2024, 20:02 | Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 20, 2024, 16:22 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Stephen Liu
At OncoDaily, we are excited to feature Dr. Stephen Liu, a preeminent thoracic oncologist, as…
Jul 18, 2024, 10:41 | Insight
Stephen Liu: Can we predict risk of immune related toxicity with immunotherapy for NSCLC
Stephen Liu shared a post on X about a recent paper by Fei Xing et…
Jul 17, 2024, 03:11 | Insight
Stephen Liu: Proud of the program we have put together for DCLung24
Stephen Liu recently shared a post on LinkedIn: “I am proud of the program we…
12
All: 123 Posts: 1 - 100
Special Coverage